Aleš Janda
Impact in
- Immunology top 10%
- Immunodeficiency and Autoimmune Disorders
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- T-cell and B-cell Immunology
-
- NF-κB Signaling Pathways
Papers in
- Immunology 14
- Immunodeficiency and Autoimmune Disorders 9
- Immune Cell Function and Interaction 6
- T-cell and B-cell Immunology 3
-
- COVID-19 Clinical Research Studies 4
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Anna Šedivá (7 shared papers)Philipp Henneke (3 shared papers)Marta Rizzi (5 shared papers)Hubert Schrezenmeier (2 shared papers)P Kasal (5 shared papers)Anne Rensing‐Ehl (4 shared papers)Stephan Ehl (4 shared papers)Klaus Schwarz (4 shared papers)
- Journals
- Blood (3 papers)Frontiers in Pediatrics (3 papers)Insights into Imaging (2 papers)PEDIATRICS (2 papers)Molecular and Cellular Pediatrics (2 papers)
- Partner nations
- GermanyCzechiaUnited States
In The Last Decade
Aleš Janda
42 papers receiving 669 citations
Peers
Comparison fields: 5 of 91
- Immunology 280
- Cancer Research 79
- Genetics 56
- Infectious Diseases 73
- Genetics 78
Countries citing papers authored by Aleš Janda
This map shows the geographic impact of Aleš Janda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aleš Janda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aleš Janda more than expected).
Fields of papers citing papers by Aleš Janda
This network shows the impact of papers produced by Aleš Janda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aleš Janda. The network helps show where Aleš Janda may publish in the future.
Co-authors
The 25 scholars most cited alongside Aleš Janda, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 121 | |
| 2 | 2010 | 54 | |
| 3 | 2007 | 39 | |
| 4 | 2021 | 33 | |
| 5 | 2014 | 29 | |
| 6 | Early development of immunity in diGeorge syndrome. | 2005 | 28 |
| 7 | 2004 | 25 | |
| 8 | 2007 | 24 | |
| 9 | 2014 | 23 | |
| 10 | 2007 | 23 | |
| 11 | 2020 | 23 | |
| 12 | 2010 | 21 | |
| 13 | 2021 | 21 | |
| 14 | 2016 | 20 | |
| 15 | 2009 | 19 | |
| 16 | 2021 | 17 | |
| 17 | 2018 | 17 | |
| 18 | 2020 | 17 | |
| 19 | 2015 | 17 | |
| 20 | 2009 | 12 |
About Aleš Janda
Aleš Janda is a scholar working on Immunology, Infectious Diseases, Surgery, Pulmonary and Respiratory Medicine and Genetics, having authored 46 papers that have together received 680 indexed citations. Recurring topics across this work include Immunodeficiency and Autoimmune Disorders (9 papers), Immune Cell Function and Interaction (6 papers), COVID-19 Clinical Research Studies (4 papers), Migration, Health and Trauma (4 papers), T-cell and B-cell Immunology (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Pneumonia and Respiratory Infections (2 papers) and Congenital heart defects research (2 papers). The work is most often cited by research in Immunology (280 citations), Cancer Research (79 citations), Genetics (56 citations), Infectious Diseases (73 citations) and Genetics (78 citations). Aleš Janda has collaborated with scholars based in Germany, Czechia and United States. Frequent co-authors include Anna Šedivá, Philipp Henneke, Marta Rizzi, Hubert Schrezenmeier, P Kasal, Anne Rensing‐Ehl, Stephan Ehl, Klaus Schwarz, Sebastian Fuchs and Radek Špíšek. Their work appears in journals such as Blood, Frontiers in Pediatrics, Insights into Imaging, PEDIATRICS and Molecular and Cellular Pediatrics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.